- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Singapore Market Expects to Reach $1.15 billion by 2021
The Singapore pharmaceutical market is predicted to grow from $903 million in 2016 to $1.15 billion by 2012, according to data and analytics company GlobalData.
The company’s latest report shows that a key driver in Singapore’s healthcare market is universal access to health insurance and world-class biomedical sciences research facilities.
The medical device market is expected to grow as Singapore strengthens its position as the region’s healthcare hub. In 2015, the medical device market contributed $1.69 billion to Singapore’s output.
View the full report here.
IMF Chief Medical Officer Discusses Global Initiatives to Improve Myeloma Treatment
August 20th 2024In an interview with Pharm Exec Associate Editor Don Tracy, Joseph Mikhael, chief medical officer, IMF, offers a glimpse at multiple initiatives that the IMF is working towards to improve myeloma treatment globally.
